Negative regulation of NEMO signaling by the ubiquitin E3 ligase MARCH2

Cited 22 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorK Chathuranga-
dc.contributor.authorTae Hwan Kim-
dc.contributor.authorH Lee-
dc.contributor.authorJ S Park-
dc.contributor.authorJae-Hoon Kim-
dc.contributor.authorW A G Chathuranga-
dc.contributor.authorP Ekanayaka-
dc.contributor.authorY J Choi-
dc.contributor.authorChul Ho Lee-
dc.contributor.authorC J Kim-
dc.contributor.authorJ U Jung-
dc.contributor.authorJ S Lee-
dc.date.accessioned2020-11-05T13:08:13Z-
dc.date.available2020-11-05T13:08:13Z-
dc.date.issued2020-
dc.identifier.issn0261-4189-
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/23203-
dc.description.abstractNF-κB essential modulator (NEMO) is a key regulatory protein that functions during NF-κB- and interferon-mediated signaling in response to extracellular stimuli and pathogen infections. Tight regulation of NEMO is essential for host innate immune responses and for maintenance of homeostasis. Here, we report that the E3 ligase MARCH2 is a novel negative regulator of NEMO-mediated signaling upon bacterial or viral infection. MARCH2 interacted directly with NEMO during the late phase of infection and catalyzed K-48-linked ubiquitination of Lys326 on NEMO, which resulted in its degradation. Deletion of MARCH2 resulted in marked resistance to bacterial/viral infection, along with increased innate immune responses both in vitro and in vivo. In addition, MARCH2-/- mice were more susceptible to LPS challenge due to massive production of cytokines. Taken together, these findings provide new insight into the molecular regulation of NEMO and suggest an important role for MARCH2 in homeostatic control of innate immune responses.-
dc.publisherWiley-
dc.titleNegative regulation of NEMO signaling by the ubiquitin E3 ligase MARCH2-
dc.title.alternativeNegative regulation of NEMO signaling by the ubiquitin E3 ligase MARCH2-
dc.typeArticle-
dc.citation.titleEMBO Journal-
dc.citation.number21-
dc.citation.endPagee105139-
dc.citation.startPagee105139-
dc.citation.volume39-
dc.contributor.affiliatedAuthorTae Hwan Kim-
dc.contributor.affiliatedAuthorJae-Hoon Kim-
dc.contributor.affiliatedAuthorChul Ho Lee-
dc.contributor.alternativeNameChathuranga-
dc.contributor.alternativeName김태환-
dc.contributor.alternativeName이현철-
dc.contributor.alternativeName박준설-
dc.contributor.alternativeName김재훈-
dc.contributor.alternativeNameChathuranga-
dc.contributor.alternativeNameEkanayaka-
dc.contributor.alternativeName최연정-
dc.contributor.alternativeName이철호-
dc.contributor.alternativeName김철중-
dc.contributor.alternativeName정재우-
dc.contributor.alternativeName이종수-
dc.identifier.bibliographicCitationEMBO Journal, vol. 39, no. 21, pp. e105139-e105139-
dc.identifier.doi10.15252/embj.2020105139-
dc.subject.keywordinnate immunity-
dc.subject.keywordMARCH2-
dc.subject.keywordNEMO-
dc.subject.keywordubiquitination-
dc.subject.localinnate immunity-
dc.subject.localInnate immunity-
dc.subject.localMARCH2-
dc.subject.localNEMO-
dc.subject.localUbiquitination-
dc.subject.localubiquitination-
dc.description.journalClassY-
Appears in Collections:
Ochang Branch Institute > Division of National Bio-Infrastructure > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.